Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 34.98% is 97% above its 5-year average of 17.72%, near the high end of its 5-year range (-42.60%–65.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.27% above its 12-month average of 28.61%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
34.98%
NET PROFIT MARGIN AVG TTM
28.61%
NET PROFIT MARGIN AVG 3Y
20.78%
NET PROFIT MARGIN AVG 5Y
18.39%
NET PROFIT MARGIN AVG 10Y
15.41%
NET PROFIT MARGIN AVG 15Y
5.64%
NET PROFIT MARGIN AVG 20Y
-37.36%
CURRENT VS TTM AVG
+22.27%
CURRENT VS 3Y AVG
+68.35%
CURRENT VS 5Y AVG
+90.21%
CURRENT VS 10Y AVG
+127.03%
CURRENT VS 15Y AVG
+520.32%
CURRENT VS 20Y AVG
+193.64%
SECTOR MEDIAN · HEALTHCARE
8.59%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+307.24%
vs the sector median at left
Incyte Corporation
Market Cap
$24.28B
Net Profit Margin
34.98%
TTM Avg
28.61%
3Y Avg
20.78%
5Y Avg
18.39%
Market Cap
$24.72B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$23.16B
Net Profit Margin
-44.73%
TTM Avg
-31.89%
3Y Avg
3.77%
5Y Avg
12.08%
Market Cap
$25.74B
Net Profit Margin
6.99%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$26.03B
Net Profit Margin
9.19%
TTM Avg
8.91%
3Y Avg
9.15%
5Y Avg
11.71%
Market Cap
$26.07B
Net Profit Margin
3.58%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
Market Cap
$22.32B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$22.03B
Net Profit Margin
41.56%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | $24.28B | 34.98% | 28.61% | 20.78% | 18.39% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 16.98% | 16.55% | 18.38% | 18.84% |
| BioNTech SE (BNTX)vs › | $23.16B | -44.73% | -31.89% | 3.77% | 12.08% |
| Labcorp Holdings Inc. (LH)vs › | $25.74B | 6.99% | 6.01% | 6.56% | 9.24% |
| STERIS plc (STE)vs › | $22.68B | 13.18% | 12.25% | 8.55% | 8.79% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.03B | 9.19% | 8.91% | 9.15% | 11.71% |
| Waters Corporation (WAT)vs › | $26.07B | 3.58% | 20.93% | 21.85% | 22.39% |
| Moderna, Inc. (MRNA)vs › | $22.32B | -141.43% | -128.24% | -70.25% | -50.87% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 41.56% | 41.73% | 40.84% | 37.71% |
| Viatris Inc. (VTRS)vs › | $20.55B | -2.04% | -14.44% | -3.94% | -4.74% |
Operating Margin
31.6%
Net Profit Margin
35.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 34.98% |
| 2026-03-31 | 23.83% |
| 2025-12-31 | 19.86% |
| 2025-09-30 | 31.05% |
| 2025-06-30 | 33.32% |
| 2025-03-31 | 15.03% |
| 2024-12-31 | 17.07% |
| 2024-09-30 | 9.36% |
| 2024-06-30 | -42.60% |
| 2024-03-31 | 19.25% |
| 2023-12-31 | 19.84% |
| 2023-09-30 | 18.64% |
| 2023-06-30 | 21.32% |
| 2023-03-31 | 2.68% |
| 2022-12-31 | 3.07% |
| 2022-09-30 | 13.70% |
| 2022-06-30 | 17.71% |
| 2022-03-31 | 5.18% |
| 2021-12-31 | 65.35% |
| 2021-09-30 | 22.35% |
| 2021-06-30 | 21.18% |
| 2021-03-31 | 8.85% |
| 2020-12-31 | 18.98% |
| 2020-09-30 | -2.45% |
| 2020-06-30 | 42.19% |
| 2020-03-31 | -126.76% |
| 2019-12-31 | 19.16% |
| 2019-09-30 | 23.26% |
| 2019-06-30 | 19.87% |
| 2019-03-31 | 20.55% |
| 2018-12-31 | 13.07% |
| 2018-09-30 | 6.49% |
| 2018-06-30 | 10.05% |
| 2018-03-31 | -10.76% |
| 2017-12-31 | -33.69% |
| 2017-09-30 | 9.45% |
| 2017-06-30 | -3.82% |
| 2017-03-31 | -48.71% |
| 2016-12-31 | 2.72% |
| 2016-09-30 | 13.69% |
| 2016-06-30 | 13.98% |
| 2016-03-31 | 9.13% |
| 2015-12-31 | 22.62% |
| 2015-09-30 | -21.10% |
| 2015-06-30 | 5.70% |
| 2015-03-31 | -11.53% |
| 2014-12-31 | -29.80% |
| 2014-09-30 | 29.92% |
| 2014-06-30 | -37.03% |
| 2014-03-31 | -37.82% |
| 2013-12-31 | -44.16% |
| 2013-09-30 | -25.89% |
| 2013-06-30 | -2.53% |
| 2013-03-31 | -22.05% |
| 2012-12-31 | 16.50% |
| 2012-09-30 | -35.89% |
| 2012-06-30 | 4.66% |
| 2012-03-31 | -125.56% |
| 2011-12-31 | -190.65% |
| 2011-09-30 | -316.28% |
| 2011-06-30 | -308.55% |
| 2011-03-31 | -82.92% |
| 2010-12-31 | 37.90% |
| 2010-09-30 | -187.89% |
| 2010-06-30 | 6.11% |
| 2010-03-31 | -206.67% |
| 2009-12-31 | -1288.12% |
| 2009-09-30 | -4617.36% |
| 2009-06-30 | -5074.14% |
| 2009-03-31 | -5966.62% |
| 2008-12-31 | -5160.45% |
| 2008-09-30 | -4221.87% |
| 2008-06-30 | -7420.68% |
| 2008-03-31 | -3072.46% |
| 2007-12-31 | -223.55% |
| 2007-09-30 | -366.13% |
| 2007-06-30 | -174.35% |
| 2007-03-31 | -298.40% |
| 2006-12-31 | -290.58% |
| 2006-09-30 | -217.91% |
| 2006-06-30 | -299.34% |
| 2006-03-31 | -267.69% |
| 2005-12-31 | -2680.54% |
| 2005-09-30 | -2460.10% |
| 2005-06-30 | -939.65% |
| 2005-03-31 | -690.60% |
| 2004-12-31 | 3567.11% |
| 2004-09-30 | -1113.89% |
| 2004-06-30 | -1587.62% |
| 2004-03-31 | -687.85% |
| 2003-12-31 | -395.87% |
| 2003-09-30 | -324.64% |
| 2003-06-30 | -243.75% |
| 2003-03-31 | -445.95% |
| 2002-12-31 | -319.13% |
| 2002-09-30 | -171.55% |
